Stay updated on NSCLC Progressed Anti-PD-1 Clinical Trial
Sign up to get notified when there's something new on the NSCLC Progressed Anti-PD-1 Clinical Trial page.

Latest updates to the NSCLC Progressed Anti-PD-1 Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedHUDSON umbrella study overview and multiple treatment arms have been added to the Study Details page, including combinations such as Durvalumab with Olaparib, Danvatirsen, Ceralasertib, Vistusertib, Oleclumab, Trastuzumab deruxtecan, and Cediranib. A 'Results Posted' update and expanded study details and locations are also included.SummaryDifference12%

- Check15 days agoNo Change Detected
- Check37 days agoChange DetectedVersion update: from v3.0.2 to v3.2.0.SummaryDifference0.1%

- Check38 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other substantive content changes detected.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed.SummaryDifference0.2%

- Check59 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%

- Check66 days agoChange DetectedThe web page has been updated to include new facility names and locations, as well as detailed drug information, including specific drugs and their availability in various locations. Additionally, a new publication related to a clinical trial has been added.SummaryDifference9%

Stay in the know with updates to NSCLC Progressed Anti-PD-1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NSCLC Progressed Anti-PD-1 Clinical Trial page.